ARTENNUA® and its great antioxidant power

In our continuous R+D processes, Biotech Tricopharming Research, in collaboration with the National Centre for Food Technology and Safety (CNTA), has carried out an evaluation of the antioxidant therapeutic potential of Artennua®, our Artemisia annua plant optimized version, compared to other aromatic and medicinal plants (MAPs) with high antioxidant properties. The evaluation is part of…

The power of herbal medicine

Medicinal plant extracts may help into treatments of epidemic diseases like COVID-19 Nowadays it is everyone’s concern about what’s COVID-19 doing to society and what are the chances to fight against it.  On March 13th, Nature Plants high-impact international  journal came out with an interesting article showing how some well recognized botanical extracts may help…

A new platform of biomolecules of industrial interest is running thanks to CDTI and our Cervera project

Validation of a biostimulation technology able to increase molecules´ and secondary metabolites concentration both in Artemisia annua plant and other Medicinal and Aromatic Plants. The project also pretends to test and validate the therapeutic and functional potential of Artennua® extract. The Centre for the Technological and Industrial Development (CDTI) by Government of Spain, approved our…

Artemisia annua

Artemisia Annua vs. Semi-Synthetic Artemisinin

Great news for Artemisia annua and our Artennua® product. A new article (Desrosiers  et al., 2020) published by the BIOMOLECULES journal and conducted by researchers at the Worcester Polytechnic Institute, USA, suggests interesting results on the bioavailability of artemisinin available between Artemisia annua plant in comparison with semi-synthetic artemisinin molecule. For the study, human liver…

New on Pubmed: artemisia annua and artemisinin effects against canine cancer

Another important article suggesting interesting conclusions about artemisia annua plant and cancer as it shows the major efficacy of the extract derived from the plant compared to the pure artemisinin (SSA, Semi Syntetic Artemisinin) against dogs cancer (osteosarcoma). The study has appeared this month on Pubmed and was conducted by researchers from the University of Bologna…